These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 20218859)
1. Lentiviral vectors for immunization: an inflammatory field. Pincha M; Sundarasetty BS; Stripecke R Expert Rev Vaccines; 2010 Mar; 9(3):309-21. PubMed ID: 20218859 [TBL] [Abstract][Full Text] [Related]
2. Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors. Dullaers M; Van Meirvenne S; Heirman C; Straetman L; Bonehill A; Aerts JL; Thielemans K; Breckpot K Gene Ther; 2006 Apr; 13(7):630-40. PubMed ID: 16355115 [TBL] [Abstract][Full Text] [Related]
3. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy. Dullaers M; Thielemans K J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497 [TBL] [Abstract][Full Text] [Related]
5. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus. Iglesias MC; Frenkiel MP; Mollier K; Souque P; Despres P; Charneau P J Gene Med; 2006 Mar; 8(3):265-74. PubMed ID: 16308885 [TBL] [Abstract][Full Text] [Related]
6. Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics. Breckpot K; Aerts JL; Thielemans K Gene Ther; 2007 Jun; 14(11):847-62. PubMed ID: 17361214 [TBL] [Abstract][Full Text] [Related]
7. Emerging applications of lentiviral vectors in dendritic cell-based immunotherapy. Wang H; Zhang L; Kung SK Immunotherapy; 2010 Sep; 2(5):685-95. PubMed ID: 20874652 [TBL] [Abstract][Full Text] [Related]
8. Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine. Wingard JB; Anderson B; Weissman D Eur J Immunol; 2008 May; 38(5):1310-20. PubMed ID: 18412164 [TBL] [Abstract][Full Text] [Related]
9. Lentiviral vector-mediated genetic programming of mouse and human dendritic cells. Stripecke R Methods Mol Biol; 2009; 506():139-58. PubMed ID: 19110625 [TBL] [Abstract][Full Text] [Related]
11. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors. Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203 [TBL] [Abstract][Full Text] [Related]
12. Lentivirus vectors: difficulties and hopes before clinical trials. Kafri T Curr Opin Mol Ther; 2001 Aug; 3(4):316-26. PubMed ID: 11525555 [TBL] [Abstract][Full Text] [Related]
13. Lentiviral vectors for HIV disease prevention and treatment. Lemiale F; Korokhov N Vaccine; 2009 May; 27(25-26):3443-9. PubMed ID: 19201386 [TBL] [Abstract][Full Text] [Related]
14. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies. Van Damme A; Chuah MK; Collen D; VandenDriessche T Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930 [TBL] [Abstract][Full Text] [Related]
15. Alteration of T cell immunity by lentiviral transduction of human monocyte-derived dendritic cells. Chen X; He J; Chang LJ Retrovirology; 2004 Nov; 1():37. PubMed ID: 15518595 [TBL] [Abstract][Full Text] [Related]
16. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo. Zhao J; Pettigrew GJ; Thomas J; Vandenberg JI; Delriviere L; Bolton EM; Carmichael A; Martin JL; Marber MS; Lever AM Basic Res Cardiol; 2002 Sep; 97(5):348-58. PubMed ID: 12200634 [TBL] [Abstract][Full Text] [Related]
17. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production. Sinn PL; Sauter SL; McCray PB Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340 [TBL] [Abstract][Full Text] [Related]